Abstract: A thermoplastic resin composition includes 100 parts by weight of a base resin including 3 to 22% by weight of an alkyl acrylate-aromatic vinyl compound-vinyl cyanide compound graft copolymer (A-1) containing alkyl acrylate rubber having an average particle diameter of 50 to 200 nm, 20 to 40% by weight of an alkyl acrylate-aromatic vinyl compound-vinyl cyanide compound graft copolymer (A-2) containing alkyl acrylate rubber having an average particle diameter of greater than 200 nm and 600 nm or less, and 50 to 72% by weight of an aromatic vinyl compound-vinyl cyanide compound copolymer (B); and 0.6 to 1.9 parts by weight of a lubricant (C), wherein, based on 100% by weight in total of the thermoplastic resin composition, a total content of rubber as measured by FT-IR is 15 to 21% by weight.

Abstract: A display device includes a light emitting element disposed on a substrate. A color conversion layer is disposed on the light emitting element, the color conversion layer including color conversion particles that convert light of a first color emitted from the light emitting element into light of a second color. An insulating layer is disposed on the color conversion layer. The insulating layer includes a first inorganic layer overlapping the color conversion layer, a second inorganic layer disposed on the first inorganic layer, and a third inorganic layer disposed on the second inorganic layer. A second porosity of the second inorganic layer is greater than a first porosity of the first inorganic layer. A second porosity of the second inorganic layer is greater than a third porosity of the third inorganic layer.

Abstract: A heat pump system for a vehicle is configured to perform cooling or heating of the vehicle interior by using a natural refrigerant, and efficiently adjust the temperature of the battery module by using a single chiller that heat-exchanges refrigerant and coolant.

Abstract: A heat pump system for a vehicle cools or heats the vehicle interior by using a natural refrigerant, and efficiently adjusts the temperature of a battery module by using a single chiller that exchanges heat between refrigerant and coolant.

Abstract: Disclosed are an apparatus and a method for compensating for a phase delay of a resolver signal. The apparatus includes an input/output interface, and a processor connected to the input/output interface, wherein the processor receives a command signal and the resolver signal through the input/output interface, calculates a delay time of the resolver signal with respect to the command signal based on the command signal and the resolver signal, calculates a compensation time based on the delay time, and compensates the command signal based on the compensation time.

Abstract: The present invention relates to a compound represented by chemical formula I, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a hydrate or solvate thereof, and a pharmaceutical composition comprising same.

Abstract: A cooling apparatus for a power module including a plurality of cooling modules provided to be in contact with each of both surfaces of the power module, in which the cooling module includes a manifold cover provided with a plurality of guide walls extending in a first direction in a state of being spaced apart from each other and a pin plate having one surface being in contact with the power module and having a plurality of pins extending in a second direction crossing the first direction formed on the other surface thereof.

Abstract: A display device includes a light emitting element disposed on a substrate. A color conversion layer is disposed on the light emitting element, the color conversion layer including color conversion particles that convert light of a first color emitted from the light emitting element into light of a second color. An insulating layer is disposed on the color conversion layer. The insulating layer includes a first inorganic layer overlapping the color conversion layer, a second inorganic layer disposed on the first inorganic layer, and a third inorganic layer disposed on the second inorganic layer. A second porosity of the second inorganic layer is greater than a first porosity of the first inorganic layer. A second porosity of the second inorganic layer is greater than a third porosity of the third inorganic layer.

Abstract: A vascular image processing method performed by a processor includes extracting, from a vascular image, a first vascular region corresponding to an entire blood vessel included in the vascular image, a second vascular region corresponding to a target vessel and one or more branch vessels connected to the target vessel, and a third vascular region corresponding to the target vessel, and predicting a vascular structure in the vascular image, based on the first vascular region, the second vascular region, and the third vascular region, which are extracted from the vascular image.

Abstract: Provided are a novel compound which can improve the luminous efficiency, stability, and service life of an element; an organic electronic element using same, and an electronic device thereof.

Abstract: A display device is disclosed that includes sub-pixels forming respective sub-pixel areas. Each of the sub-pixels may include: a display part; a sensor part disposed on the display part, and including a reflective electrode overlapping the sub-pixel areas; and an outer part disposed on the sensor part, and including a light blocking member overlapping the reflective electrode.

Abstract: A technology disclosed in the present disclosure provides a Group III-V-based quantum dot including a seed which includes a Group III element, a Group V element, and an active metal having various oxidation numbers and in which a molar ratio of the Group III element and the active metal is 1:3 to 1:30, and a method of manufacturing the same.

Abstract: A display device may include a substrate including a display area and a non-display area; and a plurality of pixels disposed in the display area, the plurality of pixels each including an emission area and a non-emission area. Each of the plurality of pixels may include at least one light emitting element in the emission area; a first pixel electrode and a second pixel electrode electrically connected to the at least one light emitting element; a bank including a first opening corresponding to the emission area; a color conversion layer disposed in the emission area to correspond to the at least one light emitting element; a barrier layer disposed on the bank and the color conversion layer; and a low refractive layer disposed on the barrier layer. The barrier layer may include silicon oxide (SiOx) having cured polysilazane.

Abstract: The present invention relates to antibody-drug conjugates (ADCs) wherein a plurality of active agents are conjugated to an antibody through at least one branched linker. The branched linker may comprise a branching unit, and two active agents are coupled to the branching unit through a secondary linker and the branching unit is coupled to the antibody by a primary linker. The active agents may be the same or different. In certain such embodiments, two or more such branched linkers are conjugated to the antibody, e.g., 2-4 branched linkers, which may each be coupled to a different C-terminal cysteine of a heavy or light chain of the antibody. The branched linker may comprise one active agent coupled to the branching unit by a first branch and a second branch that comprises a polyethylene glycol moiety coupled to the branching unit. In certain such embodiments, two or more such branched linkers are conjugated to the antibody, e.g.

Abstract: A display device according to one or more embodiments of the disclosure includes a pixel circuit layer including a base layer and circuit elements on the base layer; and a display layer on the pixel circuit layer. The display layer includes a first electrode on the pixel circuit layer; an insulating layer on the first electrode; a second electrode on the insulating layer; a light emitting stacked structure on the second electrode and including a first insulating layer, a second insulating layer, and a light emitting layer between the first insulating layer and the second insulating layer; and a third electrode on the light emitting stacked structure. The light emitting layer includes a two-dimensional material, is separated from the second electrode by the first insulating layer, and is separated from the third electrode by the second insulating layer.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: The present disclosure relates to antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-CD19 antibody through a linker. The linker may comprise a unit that covalently links active agents to the antibody. The disclosure further relates to monoclonal antibodies and antigen binding fragments, variants, multimeric versions, or bispecifics thereof that specifically bind CD19, as well as methods of making and using these anti-CD19 antibodies and antigen-binding fragments thereof in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The present invention relates to a pyrrolobenzodiazepine derivative compound, a conjugate of the same with a ligand, and the use of the same. The pyrrolobenzodiazepine derivative compound is more stable in plasma, is stable even in circulation, and exhibits excellent efficacy. In particular, the conjugate of the pyrrolobenzodiazepine derivative compound with a ligand has a great advantage in that it is possible to target and specifically treat proliferative disease such as cancer, maximize drug efficacy, and minimize the expression of side effects since the conjugate more stably reaches the target cell and effectively exerts drug efficacy while toxicity is greatly reduced as a linker technology that allows drugs to be easily released within cancer cells and maximize drug efficacy is incorporated.

Abstract: A color conversion panel includes: a substrate; a plurality of banks disposed on the substrate, where the banks partition a first light emitting region, a second light emitting region, and a third light emitting region; a first color conversion layer disposed in the first light emitting region, a second color conversion layer disposed in the second light emitting region, and a transmission layer disposed in the third light emitting region; and a first reflective layer disposed to overlap the first color conversion layer and the second color conversion layer, where the first reflective layer includes a first layer, a second layer, and a third layer, a refractive index of the second layer is greater than a refractive index of the third layer, and the refractive index of the third layer is greater than a refractive index of the first layer.

Abstract: The present invention relates to a pyrrolobenzodiazepine dimer prodrug and a ligand-linker conjugate compound thereof, a composition containing these, and therapeutic use thereof particularly as an anticancer drug. The stability of the compounds themselves and the stability thereof in plasma are excellent and the compounds are advantageous in terms of manifestation of toxicity, and thus the compounds are industrially useful in that it is possible to target proliferative diseases such as cancer, to perform a specific treatment, to maximize the drug efficacy, and to minimize the occurrence of side effects.